Moreover, serum ATX was increased in hepatocellular carcinoma with liver fibrosis, nonalcoholic fatty liver disease, and cholestatic disorders [8, 29, 30]. This evidence concerns the gene ENPP2 and metabolic dysfunction-associated steatotic liver disease.